Top Strike Resources Corp. (VENI.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.72 Million CAD | -107.99% |
| 2022 | -826.96 Thousand CAD | -4.08% |
| 2021 | -794.51 Thousand CAD | 45.76% |
| 2020 | -1.46 Million CAD | -167.86% |
| 2019 | 2.15 Million CAD | 212.82% |
| 2018 | -1.91 Million CAD | -9339.57% |
| 2017 | -20.26 Thousand CAD | 71.96% |
| 2016 | -72.28 Thousand CAD | -263.42% |
| 2015 | -19.88 Thousand CAD | 2.43% |
| 2014 | -20.38 Thousand CAD | 79.84% |
| 2013 | -101.11 Thousand CAD | -19.42% |
| 2012 | -84.67 Thousand CAD | -4.63% |
| 2011 | -80.92 Thousand CAD | -449.85% |
| 2010 | -14.71 Thousand CAD | 92.6% |
| 2009 | -198.87 Thousand CAD | 11.34% |
| 2008 | -224.32 Thousand CAD | 46.57% |
| 2007 | -419.86 Thousand CAD | 45.65% |
| 2006 | -772.46 Thousand CAD | -23.85% |
| 2005 | -623.69 Thousand CAD | 81.52% |
| 2004 | -3.37 Million CAD | -148.89% |
| 2003 | -1.35 Million CAD | -160.48% |
| 2002 | -520.47 Thousand CAD | 48.26% |
| 2001 | -1 Million CAD | 17.02% |
| 2000 | -1.21 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | -191.35 Thousand CAD | -584.62% |
| 2023 FY | -1.72 Million CAD | -107.99% |
| 2023 Q2 | 39.48 Thousand CAD | 120.14% |
| 2023 Q1 | -196.08 Thousand CAD | 68.85% |
| 2022 Q2 | -3171.00 CAD | 96.73% |
| 2022 Q3 | -102.26 Thousand CAD | -3125.04% |
| 2022 Q4 | -629.43 Thousand CAD | -515.49% |
| 2022 Q1 | -96.85 Thousand CAD | 87.99% |
| 2022 FY | -826.96 Thousand CAD | -4.08% |
| 2021 Q2 | 3873.00 CAD | -98.62% |
| 2021 Q4 | -806.21 Thousand CAD | -549.94% |
| 2021 Q1 | 280.65 Thousand CAD | 193.07% |
| 2021 Q3 | -124.04 Thousand CAD | -3302.81% |
| 2021 FY | -794.51 Thousand CAD | 45.76% |
| 2020 Q3 | -663.01 Thousand CAD | -397.22% |
| 2020 Q4 | -301.56 Thousand CAD | 54.52% |
| 2020 Q1 | -253.26 Thousand CAD | -135.53% |
| 2020 Q2 | -133.34 Thousand CAD | 47.35% |
| 2020 FY | -1.46 Million CAD | -167.86% |
| 2019 Q1 | -199.42 Thousand CAD | 85.66% |
| 2019 Q2 | -60.82 Thousand CAD | 69.5% |
| 2019 Q3 | 59.19 Thousand CAD | 197.32% |
| 2019 Q4 | 712.76 Thousand CAD | 1104.07% |
| 2019 FY | 2.15 Million CAD | 212.82% |
| 2018 Q2 | -286.79 Thousand CAD | -8630.56% |
| 2018 Q4 | -1.39 Million CAD | -497.43% |
| 2018 FY | -1.91 Million CAD | -9339.57% |
| 2018 Q1 | -3285.00 CAD | 68.68% |
| 2018 Q3 | -232.74 Thousand CAD | 18.85% |
| 2017 Q3 | -3121.00 CAD | -14.74% |
| 2017 FY | -20.26 Thousand CAD | 71.96% |
| 2017 Q1 | -3940.00 CAD | 74.97% |
| 2017 Q2 | -2720.00 CAD | 30.96% |
| 2017 Q4 | -10.48 Thousand CAD | -236.05% |
| 2016 Q1 | -3733.00 CAD | 64.04% |
| 2016 FY | -72.28 Thousand CAD | -263.42% |
| 2016 Q2 | -39.87 Thousand CAD | -968.1% |
| 2016 Q3 | -12.93 Thousand CAD | 67.56% |
| 2016 Q4 | -15.73 Thousand CAD | -21.67% |
| 2015 Q1 | -4733.00 CAD | 54.71% |
| 2015 Q4 | -10.38 Thousand CAD | -479.68% |
| 2015 FY | -19.88 Thousand CAD | 2.43% |
| 2015 Q2 | -2983.00 CAD | 36.97% |
| 2015 Q3 | -1791.00 CAD | 39.96% |
| 2014 Q2 | -3870.00 CAD | -10.41% |
| 2014 Q1 | -3505.00 CAD | 90.06% |
| 2014 FY | -20.38 Thousand CAD | 79.84% |
| 2014 Q3 | -2558.00 CAD | 33.9% |
| 2014 Q4 | -10.45 Thousand CAD | -308.56% |
| 2013 Q4 | -35.25 Thousand CAD | -82.02% |
| 2013 Q3 | -19.36 Thousand CAD | 5.01% |
| 2013 Q2 | -20.39 Thousand CAD | 21.9% |
| 2013 Q1 | -26.1 Thousand CAD | -8.82% |
| 2013 FY | -101.11 Thousand CAD | -19.42% |
| 2012 Q3 | -28.27 Thousand CAD | 0.54% |
| 2012 Q4 | -23.99 Thousand CAD | 15.16% |
| 2012 Q1 | -3972.00 CAD | 86.86% |
| 2012 FY | -84.67 Thousand CAD | -4.63% |
| 2012 Q2 | -28.43 Thousand CAD | -615.79% |
| 2011 Q2 | -12.96 Thousand CAD | 46.36% |
| 2011 Q4 | -30.21 Thousand CAD | -122.82% |
| 2011 FY | -80.92 Thousand CAD | -449.85% |
| 2011 Q1 | -24.17 Thousand CAD | -118.14% |
| 2011 Q3 | -13.56 Thousand CAD | -4.57% |
| 2010 Q2 | -50.24 Thousand CAD | 30.72% |
| 2010 Q3 | -25.21 Thousand CAD | 49.81% |
| 2010 Q4 | 133.26 Thousand CAD | 628.47% |
| 2010 FY | -14.71 Thousand CAD | 92.6% |
| 2010 Q1 | -72.52 Thousand CAD | -25.98% |
| 2009 Q4 | -57.56 Thousand CAD | 8.15% |
| 2009 FY | -198.87 Thousand CAD | 11.34% |
| 2009 Q1 | -34.75 Thousand CAD | 23.79% |
| 2009 Q3 | -62.67 Thousand CAD | -42.84% |
| 2009 Q2 | -43.87 Thousand CAD | -26.25% |
| 2008 Q4 | -45.6 Thousand CAD | 44.75% |
| 2008 FY | -224.32 Thousand CAD | 46.57% |
| 2008 Q2 | -28.43 Thousand CAD | 58.02% |
| 2008 Q3 | -82.55 Thousand CAD | -190.38% |
| 2008 Q1 | -67.72 Thousand CAD | 27.05% |
| 2007 Q4 | -92.84 Thousand CAD | 10.67% |
| 2007 FY | -419.86 Thousand CAD | 45.65% |
| 2007 Q3 | -103.92 Thousand CAD | 0.0% |
| 2006 FY | -772.46 Thousand CAD | -23.85% |
| 2005 Q1 | -217.36 Thousand CAD | 92.63% |
| 2005 Q3 | -61.88 Thousand CAD | 51.72% |
| 2005 Q2 | -128.18 Thousand CAD | 41.03% |
| 2005 Q4 | -225.94 Thousand CAD | -265.08% |
| 2005 FY | -623.69 Thousand CAD | 81.52% |
| 2004 Q4 | -2.94 Million CAD | -2878.55% |
| 2004 FY | -3.37 Million CAD | -148.89% |
| 2004 Q3 | -98.96 Thousand CAD | 18.52% |
| 2004 Q2 | -121.45 Thousand CAD | 41.13% |
| 2004 Q1 | -206.3 Thousand CAD | 73.64% |
| 2003 Q2 | -193.37 Thousand CAD | -219.06% |
| 2003 FY | -1.35 Million CAD | -160.48% |
| 2003 Q4 | -782.71 Thousand CAD | -145.33% |
| 2003 Q3 | -319.04 Thousand CAD | -64.99% |
| 2003 Q1 | -60.6 Thousand CAD | 77.61% |
| 2002 Q4 | -270.7 Thousand CAD | -48.7% |
| 2002 Q1 | -42.55 Thousand CAD | 93.52% |
| 2002 Q2 | -25.17 Thousand CAD | 40.85% |
| 2002 Q3 | -182.04 Thousand CAD | -623.18% |
| 2002 FY | -520.47 Thousand CAD | 48.26% |
| 2001 Q2 | -71.05 Thousand CAD | 52.57% |
| 2001 Q1 | -149.79 Thousand CAD | 47.81% |
| 2001 FY | -1 Million CAD | 17.02% |
| 2001 Q3 | -128.41 Thousand CAD | -80.73% |
| 2001 Q4 | -656.78 Thousand CAD | -411.47% |
| 2000 Q1 | -276.56 Thousand CAD | 0.0% |
| 2000 FY | -1.21 Million CAD | 0.0% |
| 2000 Q4 | -287.03 Thousand CAD | 29.92% |
| 2000 Q3 | -409.57 Thousand CAD | -71.17% |
| 2000 Q2 | -239.28 Thousand CAD | 13.48% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.28 Million CAD | 72.642% |
| Ayurcann Holdings Corp. | -3.96 Million CAD | 56.65% |
| Blueberries Medical Corp. | -1.63 Million CAD | -5.177% |
| The BC Bud Corporation | -1.22 Million CAD | -40.519% |
| BioNxt Solutions Inc. | -7.72 Million CAD | 77.728% |
| CordovaCann Corp. | -6.88 Million CAD | 75.017% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | 58.371% |
| Captor Capital Corp. | -11.38 Million CAD | 84.887% |
| City View Green Holdings Inc. | -2.44 Million CAD | 29.754% |
| 1CM Inc. | -913.85 Thousand CAD | -88.217% |
| Global Hemp Group Inc. | -2.58 Million CAD | 33.346% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | 63.579% |
| IM Cannabis Corp. | -9.49 Million CAD | 81.891% |
| Lobe Sciences Ltd. | -4.7 Million CAD | 63.461% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | -57.58% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 77.575% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 870.161% |
| Ovation Science Inc. | -813.14 Thousand CAD | -111.527% |
| Pharmadrug Inc. | -13.2 Million CAD | 86.971% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | 71.734% |
| RAMM Pharma Corp. | -7.72 Million CAD | 77.722% |
| RIV Capital Inc. | -106.76 Million CAD | 98.389% |
| Revive Therapeutics Ltd. | -5.61 Million CAD | 69.387% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 98.762% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 91.118% |
| 1933 Industries Inc. | -13.36 Million CAD | 87.129% |
| Red Light Holland Corp. | -7.62 Million CAD | 77.449% |
| Xebra Brands Ltd. | -1.95 Million CAD | 12.126% |
| Adastra Holdings Ltd. | -3.54 Million CAD | 51.475% |